Geistlich Pharma

Geistlich Pharma, established in 1851, stands as a distinguished global leader in the field of regenerative dentistry and related medical disciplines. With a rich history spanning over a century, the company specializes in developing and providing cutting-edge biomaterials designed for dental, orthopedic, and infectiology professionals. Operating across 4 distinct locations, Geistlich Pharma has cultivated a significant international presence, underscoring its commitment to serving a worldwide market. Its foundational expertise lies in pioneering solutions that address complex medical needs through advanced biological materials.

The company's comprehensive product portfolio is engineered to facilitate superior bone and soft tissue regeneration, cartilage repair, and effective advanced wound care. These innovative offerings are crucial for professionals seeking to enhance clinical outcomes and improve the quality of life for patients undergoing various treatments. Geistlich Pharma's dedication to research and development ensures its solutions remain at the forefront of medical science, supporting practitioners in achieving optimal patient results. Meet Geistlich Pharma's team to learn more about the experts driving these critical innovations.

Geistlich Pharma generates an annual revenue of $61.5M and employs between 500 - 1,000 individuals across its operations. The company effectively serves both business-to-business (B2B) and business-to-consumer (B2C) segments, providing essential biomaterials and treatment solutions. Its strategic focus on regenerative medicine positions it as a key player in advancing patient care and therapeutic possibilities within the medical and dental industries. The company's long-standing presence and continuous innovation highlight its enduring impact on healthcare.